James Campbell JR. in Pine Bluff, Arkansas

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1982
The Primary Medical Specialty for James Campbell JR. is listed as: Nephrology
Approximate Years of Experience: 42
PAC (PECOS ID)#: 2163424292
NPI #: 1689789984
NPI Created On: 08/20/2006
NPI Last Updated Listed as: 04/28/2023
Primary Taxonomy Code: 207RN0300X
License Number:
N7871
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Ambetter
• QualChoice Life & Health Insurance Company, Inc.
• USAble Mutual Insurance Company
• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, ENGL.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Vaccine for influenza for injection into muscle
3. Hemodialysis procedure with one physician evaluation
4. Dialysis services (4 or more physician visits per month), patient 20 years of age and older
5. Dialysis services (2-3 physician visits per month), patient 20 years of age and older
6. Dialysis services (1 physician visit per month), patient 20 years of age and older
7. Home dialysis services per month, patient 20 years of age or older
8. Dialysis services, per day (less than full month service), patient 20 years of age or older
9. New patient office or other outpatient visit, typically 30 minutes
10. Established patient office or other outpatient visit, typically 15 minutes
11. Established patient office or other outpatient visit, typically 15 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Initial hospital inpatient care, typically 50 minutes per day
14. Subsequent hospital inpatient care, typically 15 minutes per day
15. Subsequent hospital inpatient care, typically 25 minutes per day
16. Physician telephone patient service, 11-20 minutes of medical discussion
17. Physician telephone patient service, 21-30 minutes of medical discussion
18. Administration of influenza virus vaccine